Towards Healthcare
Non-Steroidal Anti-Inflammatory Drugs Market to Drive USD 37.73 Bn by 2035

Non-Steroidal Anti-Inflammatory Drugs Market Growth Driven by Innovation

Based on market forecasts, the global Non-steroidal anti-inflammatory drugs market, projected at USD 23.16 billion in 2025, is expected to reach USD 37.73 billion by 2035, growing at a CAGR of 5% over the forecast period. Arthritis dominated the NSAIDs market with a 38% share. Oral administration was the top choice (56%) for its ease of use. Retail pharmacies led distribution, holding 46% of the market. North America remained the largest market for NSAIDs, driving growth and demand in the sector.

Last Updated : 17 November 2025 Category: Therapeutic Area Insight Code: 5132 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Cancer Vaccines Market Assessment

  • Overview
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Cancer Vaccines Market Assessment

  • Overview
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Europe Cancer Vaccines Market Assessment

  • Overview
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Asia Pacific Cancer Vaccines Market Assessment

  • Overview
  • Asia Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Asia Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Asia Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Middle East and Africa Cancer Vaccines Market Assessment

  • Overview
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

South America Cancer Vaccines Market Assessment

  • Overview
  • South America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • South America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • South America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Company Profiles

  • Pfizer Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Merck & Co., Inc.
  • Novartis AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • Bayer AG
  • Dr. Reddy's Laboratories Ltd.
  • Viatris Inc
  • AstraZeneca
  • Abbott Laboratories

Conclusion & Recommendations

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The NSAIDs market is projected to rise from USD 23.16 billion in 2025 to USD 24.32 billion in 2026 and reach USD 37.73 billion by 2035, driven by a steady 5% CAGR.

Arthritis remains the top contributor, capturing 38% of the market due to its high global prevalence, especially among aging adults.

NSAIDs are widely preferred over opioids because they effectively relieve pain with far lower addiction risks and fewer severe side effects.

The driving factors of non-steroidal anti-inflammatory drugs include their efficacy in managing pain and inflammation, widespread availability, and diverse applications across various medical conditions.

World Health Organization, Food and Drug Administration, National Institute of Health, ScienceDirect, PubMed.gov.
Any Questions